Educational Session 13: Optimizing Cardiac Outcomes in Breast Cancer—The Next Chapter
Session Details
This session will address cardiotoxicities of novel breast cancer therapies, strategies for risk assessment and cardioprotection, and innovative clinical trial approaches to improve cardiac outcomes.
Moderator
Alexandra Thomas, Duke University, Durham, NC
Presentation numberED13-01
Cardiotoxicity of breast cancer novel therapies
Anne H Blaes, University of Minnesota, Minneapolis, MN
Presentation numberED13-02
Approaches for cardioprotection in cancer care
Eric H Yang, UCLA, Los Angeles, CA
Presentation numberED13-03
Trial strategies to optimize cardiac outcomes
Javid Moslehi, University of California San Francisco, San Francisco, CA
Advocate
Aj Veach, Savvy Cooperative, Washington D.C., MD